Alpha Profiles · Company Profile

Cogent Biosciences, Inc.

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/cogent-biosciences-inc

Entity: Public listing published
Primary listing: NASDAQ: COGT
Verification: Partially verified
Last reviewed: 2026-10-03T04:45:32.808255+00:00

Overview

Alpha's canonical identity and public leadership record for Cogent Biosciences, Inc..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

7 public records

Andrew Robbins

Chief Executive Officer, President and Director

State: confirmed
Effective: From Feb 17, 2026
Confidence: 94%
Evidence: COGT 10-K executive officersFeb 17, 2026

Cole Pinnow

Chief Commercial Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: COGT executive roster sourceMay 3, 2026

Evan Kearns

Chief Operating Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: COGT executive roster sourceMay 3, 2026

Jay Green

Chief Financial Officer

State: confirmed
Effective: From Feb 17, 2026
Confidence: 94%
Evidence: COGT 10-K executive officersFeb 17, 2026

Jessica Sachs

Chief Medical Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: COGT executive roster sourceMay 3, 2026

John Green

Chief Financial Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: COGT executive roster sourceMay 3, 2026

John Robinson

Chief Technology Officer

State: confirmed
Effective: Date not stated
Confidence: 94%
Evidence: COGT executive roster sourceMay 3, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Oct 3, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.

Board roles

3 public records

Arlene M. Morris

Director

IndependentAuditCompensation

State: confirmed
Effective: From Jan 1, 2019
Confidence: 85%
Evidence: Cogent Biosciences, Inc. DEF 14A 2026-04-23Apr 23, 2026

Chris Cain, Ph.D.

Director

Independent

State: confirmed
Effective: From Jan 1, 2020
Confidence: 85%
Evidence: Cogent Biosciences, Inc. DEF 14A 2026-04-23Apr 23, 2026

Todd Shegog

Director

IndependentAudit · ChairCompensation

State: confirmed
Effective: From Jan 1, 2021
Confidence: 85%
Evidence: Cogent Biosciences, Inc. DEF 14A 2026-04-23Apr 23, 2026

Committees

2 public records

Membership and chair roles are projected from current board seats. A chair is shown only when a stored chair flag says so.

Audit

Chair: Todd Shegog
Members: Todd Shegog (Chair); Arlene M. Morris

Compensation

Chair: Not stated
Members: Arlene M. Morris; Todd Shegog

Source record

Alpha canonical company public projection

Supports Company identity, Published leadership, Entity status boundary

Reviewed 2026-10-03T04:45:32.808255+00:00